NEOGEN CORP
Company Information
Industry
In Vitro & In Vivo Diagnostic Substances
SIC Code
2835
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
MI
Business Address
620 LESHER PLACE, LANSING, MI, 48912
Mailing Address
620 LESHER PLACE, LANSING, MI, 48912
Phone
5173729200
Fiscal Year End
0531
EIN
382367843
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4/A Insider transaction amendment | January 29, 2026 | View on SEC |
| 3 Initial insider ownership report | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
Insider Trading
BUY
1 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
Aspira Women's Health Inc.
AWHL
In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX
In Vitro & In Vivo Diagnostic Substances
IMMUCELL CORP /DE/
ICCC
In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX
In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV
In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.